Role of Hcp, a type 6 secretion system effector, of Aeromonas hydrophila in modulating activation of host immune cells.
Recently, we reported that the type 6 secretion system (T6SS) of Aeromonas hydrophila SSU plays an important role in bacterial virulence in a mouse model, and immunization of animals with the T6SS effector haemolysin co-regulated protein (Hcp) protected them against lethal infections with wild-type bacteria. Additionally, we showed that the mutant bacteria deleted for the vasH gene within the T6SS gene cluster did not express the hcp gene, while the vasK mutant could express and translocate Hcp, but was unable to secrete it into the extracellular milieu. Both of these A. hydrophila SSU mutants were readily phagocytosed by murine macrophages, pointing to the possible role of the secreted form of Hcp in the evasion of the host innate immunity. By using the ΔvasH mutant of A. hydrophila, our in vitro data showed that the addition of exogenous recombinant Hcp (rHcp) reduced bacterial uptake by macrophages. These results were substantiated by increased bacterial virulence when rHcp was added along with the ΔvasH mutant in a septicaemic mouse model of infection. Analysis of the cytokine profiling in the intraperitoneal lavage as well as activation of host cells after 4&emsp14;h of infection with the ΔvasH mutant supplemented with rHcp indicated that this T6SS effector inhibited production of pro-inflammatory cytokines and induced immunosuppressive cytokines, such as interleukin-10 and transforming growth factor-β, which could circumvent macrophage activation and maturation. This mechanism of innate immune evasion by Hcp possibly inhibited the recruitment of cellular immune components, which allowed bacterial multiplication and dissemination in animals, thereby leading to their mortality.
Suarez
Giovanni
G
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Sierra
Johanna C
JC
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Kirtley
Michelle L
ML
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Chopra
Ashok K
AK
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
D016980:Aeromonas hydrophila / Q000235:genetics / Q000276:immunology* / Q000472:pathogenicity; D000818:Animals; D001426:Bacterial Proteins / Q000235:genetics / Q000276:immunology*; D002460:Cell Line; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000276:immunology* / Q000382:microbiology*; D006801:Humans; D051379:Mice; D010587:Phagocytosis; D021381:Protein Transport; D014774:Virulence
D001426:Bacterial Proteins
Vet Microbiol. 2010 Aug 26;144(3-4):371-6
20185253
Microbes Infect. 2009 Feb;11(2):205-14
19073275
Nat Rev Microbiol. 2010 Feb;8(2):117-28
20075926
Infect Immun. 2000 May;68(5):2808-18
10768977
Microb Pathog. 2007 Oct;43(4):147-60
17582731
Cold Spring Harb Symp Quant Biol. 1999;64:429-35
11232318
EMBO J. 1999 Jul 15;18(14):3924-33
10406797
Microbes Infect. 1999 Nov;1(13):1129-37
10572317
Science. 1999 Nov 19;286(5444):1561-5
10567263
Nat Rev Immunol. 2005 Dec;5(12):953-64
16322748
Nat Immunol. 2002 Apr;3(4):354-9
11912497
Annu Rev Immunol. 1993;11:165-90
8386517
Microb Pathog. 2010 Sep;49(3):122-34
20553837
Science. 2002 Sep 20;297(5589):2048-51
12202685
Protein Sci. 2008 Oct;17(10):1748-60
18662905
Science. 2003 Jun 6;300(5625):1524-5
12791976
Infect Immun. 2005 Oct;73(10):6446-57
16177316
J Immunol. 2002 May 1;168(9):4601-11
11971008
Nat Med. 2002 Jun;8(6):625-9
12042815
Nat Rev Immunol. 2008 Dec;8(12):958-69
19029990
J Exp Med. 2004 Jan 5;199(1):1-4
14707110
Nat Rev Immunol. 2003 Jan;3(1):23-35
12511873
Clin Infect Dis. 1998 Aug;27(2):332-44
9709884
Annu Rev Immunol. 2002;20:197-216
11861602
Curr Opin Microbiol. 2009 Feb;12(1):11-7
19162533
Trends Immunol. 2004 Dec;25(12):677-86
15530839
J Biol Chem. 2004 May 7;279(19):20044-8
15014080
Cell Host Microbe. 2009 Mar 19;5(3):234-43
19286133
Curr Biol. 2004 Oct 5;14(19):R856-67
15458668
Science. 1994 Feb 4;263(5147):678-81
8303277
EMBO Rep. 2008 Aug;9(8):735-41
18617888
Biochem J. 2001 Jan 1;353(Pt 1):109-116
11115404
Cell Microbiol. 2007 Nov;9(11):2700-15
17608743
Microb Pathog. 2008 Apr;44(4):344-61
18037263
Expert Rev Mol Med. 2006 Nov 22;8(28):1-25
17118220
Placenta. 2009 Jan;30(1):11-4
19036437
J Cell Biol. 2002 Mar 18;156(6):943-6
11901162
EMBO Rep. 2006 Aug;7(8):838-44
16845370
In Silico Biol. 2003;3(3):287-300
12954091
J Immunol. 2002 Jun 15;168(12):6404-11
12055259
Nat Immunol. 2002 Nov;3(11):1033-40
12407412
Curr Opin Microbiol. 2008 Feb;11(1):3-8
18289922
J Bacteriol. 2010 Jan;192(1):155-68
19880608
Infect Immun. 1998 Aug;66(8):3501-9
9673226
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4365-70
20150509
Curr Opin Immunol. 2006 Feb;18(1):49-53
16338128
Mol Microbiol. 1996 Aug;21(3):433-40
8866467
J Exp Med. 2002 Jan 21;195(2):221-31
11805149
Microb Pathog. 2007 Oct;43(4):127-46
17644303
J Immunol. 2002 Feb 1;168(3):1315-21
11801671
Annu Rev Microbiol. 2005;59:69-89
15847602
Appl Environ Microbiol. 2009 Oct;75(19):6382-92
19684162
Mol Immunol. 2002 Dec;39(9):531-6
12431386
Annu Rev Immunol. 2005;23:901-44
15771589
Cell Microbiol. 2006 May;8(5):728-37
16611223
J Immunol. 2008 Nov 1;181(9):5829-35
18941170
Clin Immunol. 2005 Mar;114(3):216-26
15721832
Microbiology (Reading). 2008 Jun;154(Pt 6):1570-1583
18524912
J Leukoc Biol. 2003 Feb;73(2):209-12
12554797